1. Home
  2. WVE vs AROW Comparison

WVE vs AROW Comparison

Compare WVE & AROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$3.37

Market Cap

673.9M

Sector

Health Care

ML Signal

N/A

Logo Arrow Financial Corporation

AROW

Arrow Financial Corporation

N/A

Current Price

$38.62

Market Cap

727.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
AROW
Founded
2012
1851
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
673.9M
727.7M
IPO Year
2015
1995

Fundamental Metrics

Financial Performance
Metric
WVE
AROW
Price
$3.37
$38.62
Analyst Decision
Strong Buy
Hold
Analyst Count
21
4
Target Price
$17.05
★ $43.50
AVG Volume (30 Days)
★ 2.9M
60.0K
Earning Date
10-27-2026
10-29-2026
Dividend Yield
N/A
★ 3.11%
EPS Growth
N/A
★ 49.72
EPS
N/A
★ 1.48
Revenue
★ $3,704,000.00
N/A
Revenue This Year
$48.79
$26.11
Revenue Next Year
N/A
$15.43
P/E Ratio
★ N/A
$26.72
Revenue Growth
★ 149.43
N/A
52 Week Low
$3.04
$28.92
52 Week High
$21.73
$42.70

Technical Indicators

Market Signals
Indicator
WVE
AROW
Relative Strength Index (RSI) 43.99 54.28
Support Level $3.04 $37.23
Resistance Level $3.97 $40.13
Average True Range (ATR) 0.24 1.03
MACD 0.05 0.13
Stochastic Oscillator 35.14 52.17

Price Performance

Historical Comparison
WVE
AROW

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About AROW Arrow Financial Corporation

Arrow Financial Corp is a holding company. It provides various advisory and administrative services and coordinates the general policies and operations of the banks. It provides financial products, including online and mobile banking, mortgages, commercial loans, investments, and others. The company also provides lending services, including commercial and industrial lending to small and mid-sized companies; mortgage lending for residential and commercial properties; and consumer installment and home equity financing. The key source of the company's revenue is interest income, fees, commission earned through its subsidiaries.

Share on Social Networks: